McCabe Cindy, Harrawood Brian, Samei Ehsan, Abadi Ehsan
Center for Virtual Imaging Trials, Duke University, Durham, North Carolina, USA.
Med Phys. 2025 Jun;52(6):3840-3853. doi: 10.1002/mp.17886. Epub 2025 May 13.
Computed tomography (CT) is rapidly advancing with the recent FDA clearance of photon-counting CT (PCCT) systems for clinical use. New technologies are best evaluated using physical phantoms or patient images. However, both methods have their drawbacks: physical phantoms lack the complexity and diversity to be representative of a human population, and patient images lack the ground truth and are often cost- and time-prohibitive. Virtual imaging trials, also known as in silico trials, can mitigate these limitations by using computer simulations to conduct imaging experiments to assess the safety and efficacy of new medical technologies for specific clinical conditions. However, to date, there have been no simulation platforms to assess PCCT systems generalizable across clinical imaging conditions.
The purpose of this study was to develop and validate a computationally-efficient CT simulator that realistically accounts for conditions of a clinical PCCT system to be used for in silico trials.
The simulator was built upon a state-of-the-art platform (DukeSim) which simulates CT projection images of computational phantoms given the geometry and physics of the scanner and acquisition settings. To model the photon-counting detection process, we utilized a spatio-energetic detector model based on Monte Carlo simulations with known properties of the detectors. DukeSim was augmented to account for the geometry and physics of a clinical PCCT system (NAEOTOM Alpha, Siemens), including correlated noise between detector thresholds, and low-signal physics for photon starved regions. We validated the simulation platform against experimental measurements using two physical phantoms scanned with a clinical PCCT scanner. The ACR phantom-a cylindrical phantom with four inserts was used to validate the simulator across a clinically relevant dose range with images acquired at four dose levels (CTDI of 1.5-12.0 mGy). The Mercury phantom-a cylindrical phantom with five diameters (160-360 mm) was used to validate the simulator for a range of patient sizes. The experimental acquisitions were replicated using our developed simulation platform. Each acquisitions was reconstructed using ReconCT with three kernels at a 0.4 mm slice thickness. The real and simulated images were quantitatively compared in terms of image quality metrics. Further, the simulation spatial resolution uncertainty from input parameters was quantified in terms of the MTF.
The developed simulator generated images that were close to the experimental scans. In terms of noise magnitude, the discrepancy between real and simulated data were 2.78 ± 3.02% and 2.67 ± 1.53%, for the ACR and Mercury phantom, respectively. In terms of the frequency at 50% MTF, the discrepancy between real and simulated data were 0.05 and 0.03 mm, for the ACR and Mercury phantom, respectively. Subsampling had a strong effect on the MTF measurement ( = [0.25, 1.12]), while voxel size had a weaker effect ( = [0.48, 0.55]).
We successfully developed and validated a virtual imaging platform for a current PCCT system, enabling the optimization of imaging parameters (including dose optimization) for specific clinical tasks, as well as comparisons across CT systems.
随着美国食品药品监督管理局(FDA)近期批准光子计数CT(PCCT)系统用于临床,计算机断层扫描(CT)技术正在迅速发展。使用物理体模或患者图像对新技术进行评估最为理想。然而,这两种方法都有其缺点:物理体模缺乏代表人群的复杂性和多样性,而患者图像缺乏真实情况,且成本高、耗时久。虚拟成像试验,也称为计算机模拟试验,可以通过使用计算机模拟进行成像实验来评估特定临床条件下新医疗技术的安全性和有效性,从而减轻这些限制。然而,迄今为止,还没有可在临床成像条件下通用的评估PCCT系统的模拟平台。
本研究的目的是开发并验证一种计算效率高的CT模拟器,该模拟器能真实地反映临床PCCT系统的情况,用于计算机模拟试验。
该模拟器基于一个先进的平台(DukeSim)构建,该平台根据扫描仪的几何结构和物理特性以及采集设置来模拟计算体模的CT投影图像。为了模拟光子计数检测过程,我们利用了基于蒙特卡罗模拟的空间能量探测器模型,该模型具有探测器的已知特性。对DukeSim进行了扩展,以考虑临床PCCT系统(西门子的NAEOTOM Alpha)的几何结构和物理特性,包括探测器阈值之间的相关噪声以及光子饥饿区域的低信号物理特性。我们使用临床PCCT扫描仪扫描的两个物理体模,通过实验测量对模拟平台进行了验证。使用ACR体模(一个带有四个插入物的圆柱形体模)在四个剂量水平(CTDI为1.5 - 12.0 mGy)采集图像,以在临床相关剂量范围内验证模拟器。使用Mercury体模(一个有五个直径(160 - 360 mm)的圆柱形体模)来验证模拟器对一系列患者体型的适用性。使用我们开发的模拟平台复制实验采集。每个采集使用ReconCT以0.4 mm的切片厚度和三个内核进行重建。从图像质量指标方面对真实图像和模拟图像进行定量比较。此外,根据调制传递函数(MTF)对输入参数的模拟空间分辨率不确定性进行了量化。
所开发的模拟器生成的图像与实验扫描图像接近。在噪声幅度方面,ACR体模和Mercury体模的真实数据与模拟数据之间的差异分别为2.78±3.02%和2.67±1.53%。在50% MTF频率方面,ACR体模和Mercury体模的真实数据与模拟数据之间的差异分别为0.05和0.03 mm。子采样对MTF测量有很大影响(范围为[0.25, 1.12]),而体素大小的影响较小(范围为[0.48, 0.55])。
我们成功开发并验证了一个用于当前PCCT系统的虚拟成像平台,可针对特定临床任务优化成像参数(包括剂量优化),并可在不同CT系统之间进行比较。